Sign in

CIK 0001621227

  • Non-accelerated filer
  • Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1235430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-02-20 Lunger John Chief Patient Supply Officer Grant or award · Option to purchase Ordinary Shares +1,612,032 1,612,032
2025-02-20 Lunger John Chief Patient Supply Officer Grant or award · Option to purchase Ordinary Shares +1,074,696 1,074,696
2025-01-17 Lunger John Chief Patient Supply Officer Sale −5,584 $0.58 $3K 7,510
2025-01-15 Lunger John Chief Patient Supply Officer Sale −9,803 $0.57 $6K 13,756
2025-01-13 Lunger John Chief Patient Supply Officer Sale −4,268 $0.59 $3K 5,845
2025-01-13 Lunger John Chief Patient Supply Officer Sale −5,471 $0.59 $3K 7,623
2024-01-17 Lunger John Chief Patient Supply Officer Sale −5,309 $0.67 $4K 7,785
2024-01-17 Lunger John Chief Patient Supply Officer Sale −12,805 $0.67 $9K 19,015
2024-01-16 Lunger John Chief Patient Supply Officer Sale −4,681 $0.79 $4K 7,023
2024-01-15 Lunger John Chief Patient Supply Officer Grant or award · Option to purchase Ordinary Shares +2,544,432 2,544,432
2024-01-15 Lunger John Chief Patient Supply Officer Grant or award · Option to purchase Ordinary Shares +565,416 565,416
2024-01-12 Lunger John Chief Patient Supply Officer Sale −5,220 $0.85 $4K 7,874
2024-01-11 Lunger John Chief Patient Supply Officer Sale −4,009 $0.84 $3K 6,104
2023-08-01 Lunger John Chief Patient Supply Officer Sale −3,096 $0.91 $3K 4,718
2023-01-17 Lunger John Chief Patient Supply Officer Sale −4,440 $1.86 $8K 7,264
2023-01-17 Lunger John Chief Patient Supply Officer Grant or award · Option to purchase Ordinary Shares +1,407,072 1,407,072
2023-01-17 Lunger John Chief Patient Supply Officer Grant or award · Option to purchase Ordinary Shares +314,256 314,256
2023-01-17 Lunger John Chief Patient Supply Officer Grant or award · Option to purchase Ordinary Shares +190,920 190,920
2023-01-12 Lunger John Chief Patient Supply Officer Sale −4,973 $1.71 $8K 8,121
2023-01-11 Lunger John Chief Patient Supply Officer Sale −3,843 $1.75 $7K 6,270

Page 1 of 3 · 43 trades